首页> 外文期刊>Cancer genomics & proteomics >Oligonucleotide Array Comparative Genomic Hybridization Profiling of Neuroblastoma Tumours
【24h】

Oligonucleotide Array Comparative Genomic Hybridization Profiling of Neuroblastoma Tumours

机译:神经母细胞瘤肿瘤的寡核苷酸阵列比较基因组杂交分析。

获取原文
           

摘要

Neuroblastoma (NB) is one of the most common paediatric solid tumours and displays a broad variety of genomic alterations. Recently, array comparative genomic hybridization (aCGH) has emerged as a novel technology enabling high-resolution detection of DNA copy number aberrations. We have previously optimized a custom cDNA-array to detect MYCN gain and chromosome 1p36 loss, two molecular markers of tumour aggressiveness in NB. In spite of the power of this technique, the production of cDNA arrays is time-consuming and expensive. In the present study, we report a printed 55-mer oligonucleotide aCGH with the aim of increasing the resolution and the sensitivity of our platform. The oligonucleotide probes, designed and validated for expression profiling, reproducibly assessed amplifications, even when using whole genomes as targets. On the contrary, this microarray platform seems to offer little accuracy in measuring genomic single-copy deletions. Therefore, an oligo library specifically designed for aCGH should improve the performance of oligonucleotide aCGH in accurately mapping unbalanced chromosomal abnormalities.
机译:神经母细胞瘤(NB)是最常见的小儿实体瘤之一,显示出各种各样的基因组改变。最近,阵列比较基因组杂交(aCGH)作为一种新技术出现,能够高分辨率检测DNA拷贝数畸变。我们之前已经优化了定制的cDNA阵列,以检测MYCN增益和1p36染色体丢失,这是NB中肿瘤侵袭性的两个分子标记。尽管该技术具有强大功能,但生产cDNA阵列既费时又昂贵。在本研究中,我们报告了印刷的55-mer寡核苷酸aCGH,旨在提高我们平台的分辨率和灵敏度。设计和验证表达谱的寡核苷酸探针,即使使用整个基因组作为靶标,也可重复评估扩增。相反,这种微阵列平台似乎在测量基因组单拷贝缺失方面几乎没有准确性。因此,专为aCGH设计的寡核苷酸文库应改善寡核苷酸aCGH在准确定位不平衡染色体异常中的性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号